Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc    

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 21 538 M
EBIT 2015 9 315 M
Net income 2015 2 986 M
Debt 2015 41 745 M
Yield 2015 0,01%
Sales 2016 24 820 M
EBIT 2016 11 784 M
Net income 2016 4 903 M
Debt 2016 31 151 M
Yield 2016 0,02%
PER 2015 41,57
PER 2016 23,45
EV / Sales 2015 8,04x
EV / Sales 2016 6,55x
Capitalization 131 438 M
More Financials
Company
Allergan Plc operates as an investment holding company.It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products.The company operates through the following segments: North... 
Sector
Pharmaceuticals
Calendar
08/06Earnings Release
More about the company
Surperformance© ratings of Actavis Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACTAVIS INC
06:15aDJShire Mounts $30.6 Billion Bid for Biotech
07/31 Healthcare deals lift July to seventh busiest M&A month on record
07/30DJTeva Profit Falls on Legal Expenses
07/30DJTeva Profit Falls as Legal and Restructuring Expenses Rise
07/30 Teva's MS drug Copaxone has strong second-quarter sales
07/29DJMylan Gets European Regulator's Approval for Perrigo Deal
07/29DJMylan Gets European Regulator's Approval for Perrigo Deal
07/28 Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
More news
Sector news : Pharmaceuticals - NEC
08:21p ASTRAZENECA : completes agreement with Tillotts Pharma for Entocort
05:55pDJShire Offers to Buy Baxalta for $30.6 Billion -- 9th Update
05:08p ELI LILLY : Lilly to End Contract with the University of California, San Diego f..
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions